2023/09/04 Is THC the key to resolving alzheimer’s disease? NYSE American-listed IGC Corp. is hoping so as the company continues to conduct research using cannabinoid drugs, THC and CBD, to treat different symptoms, including Alzheimer’s Disease, seizures, and chronic pain. In fact, IGC shares some details, including the positive effect of its IGC-AD1 drug on neuropsychiatric symptoms in dementia.

Subscribe NOW to Modern Wall Street: http://bit.ly/2wsU9rO

Get more Modern Wall Street:
Like Modern Wall Street: http://Facebook.com/modernwallstreet/
Follow Modern Wall Street: http://Twitter.com/ModernWallSt
Insta Follow: http://Instagram.com/modernwallstreet/

source